SEC Filing Details

Document Details

Form

SC TO-I/A

Filing Date

Nov 1, 2010

Document Date

Nov 1, 2010

Form Description

Amendment to a previously filed SC TO-I

Filing Group

Other

Company

ReShape Lifesciences

Issuer

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE

SEC Filing Details

SEC Filing Details

Document Details

Filing Formats

Overview

Events and Presentations

Press Releases

SEC Filings

Stock Information

Management

Corporate Governance

Investor FAQs

Email Alerts